all report title image
  • Published On : Sep 2020
  • Code : CMI4156
  • Industry : Medical Devices
  • Pages : 157
  • Formats :

Blood transfusion is process of transfusion of blood and blood components to the patient’s body to replace the lost components of the blood.

The most commonly performed surgeries that require blood transfusion include cardiovascular procedures, C-section procedures, and trauma and accident injuries. As per estimates by the NIH and National Heart, Lung, and Blood Institute, blood transfusions are very common in the U.S., as each year, over 5 million Americans need blood transfusions, which increases the demand for blood transfusion devices.

The global blood transfusion devices market is estimated to be valued at US$ 4,189.6 million in 2020 and is expected to exhibit a CAGR of 5.7% during the forecast period (2020-2027).

Figure 1: Blood Transfusion Devices Market Share (%) Analysis, By Region, 2020

Blood Transfusion Devices  | Coherent Market Insights

The increasing prevalence of blood-related disorders and chronic kidney disorders across the globe is expected to drive the global blood transfusion devices market growth

According to the American Cancer Society, currently, around 1.32 million people are living with leukemia and lymphoma disorder. Furthermore, according to the National Kidney Foundation 2015, around 10% of the population worldwide is affected by chronic kidney disorder (CKD) and millions die each year because of unaffordable treatment.

Thus, high prevalence and rising incidence of chronic diseases have increased demand for blood and blood products, which is expected to drive the global blood transfusion devices market growth.

CMI table icon

Blood Transfusion Devices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 4,189.6 Mn
Historical Data for: 2017 to 2019 Forecast Period: 2021 to 2027
Forecast Period 2020 to 2027 CAGR: 5.7% 2027 Value Projection: US$ 6,209.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others.
  • By End User: Hospital, Ambulatory Surgical Centers, Others.
Companies covered:

Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company

Growth Drivers:
  • Increasing prevalence of blood-related disorders and chronic kidney disorders
  • Increasing Launches of Blood Transfusion Devices

Blood Transfusion Devices Market– Regional Analysis

North America accounted for the largest share in the blood transfusion devices market in 2019, owing to increasing demand for blood transfusion in the U.S. For instance, according to the American National Red Cross, approximately 36,000 units of red blood cells are needed every day and around 21 million blood components are transfused each year in the U.S.

Furthermore, Asia Pacific is expected to witness fastest growth during the forecast period, owing to increasing healthcare expenditure in emerging economies such as China and India. For instance, according to the National Health Expenditure, the total expenditure in the healthcare sector in India was US$ 133 billion in 2016.

Figure 2: Blood Transfusion Devices Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Blood Transfusion Devices  | Coherent Market Insights

Blood Transfusion Devices Market- Competitive Landscape

Key players operating in the blood transfusion devices market include Fresenius Kabi AG,  Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company.

Blood transfusion is the process of adding blood into the body after a serious injury or illness. The process of blood transfusion is carried out by placing a venous access device and catheter into either a peripheral or central vein or passing the blood or blood component through an infusion pump or apheresis systems.

The blood transfusion process has wide applications in the treatment of various medical conditions such as blood disorders, autoimmune disorders, cancer, renal disorders, surgical procedures, and others.

Market Dynamics

The global blood transfusion devices market is expected to witness significant growth during the forecast period, owing to increasing number of accidents. Accidents result in severe blood loss, which increases demand for blood transfusion. For instance, according to the World Health Organization (WHO) 2020, approximately 1.35 million people die each year due to road accidents, and between 20 and 50 million people suffer from non-fatal injuries, globally.

Key features of the study:

  • This report provides in-depth analysis of the global blood transfusion devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global blood transfusion devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global blood transfusion devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the blood transfusion devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Blood Transfusion Devices Market, By Product Type:
    • Apheresis Systems
    • Infusion Devices
    • Blood Warmers
    • Venous Access Devices
    • Filters
    • Others
  • Global Blood Transfusion Devices Market, By End User:
    • Hospital
    • Ambulatory Surgical Centers
    • Others
  • Global Blood Transfusion Devices Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Apheresis Systems
        • Infusion Devices
        • Blood Warmers
        • Venous Access Devices
        • Filters
        • Others
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Apheresis Systems
        • Infusion Devices
        • Blood Warmers
        • Venous Access Devices
        • Filters
        • Others
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Apheresis Systems
        • Infusion Devices
        • Blood Warmers
        • Venous Access Devices
        • Filters
        • Others
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Apheresis Systems
        • Infusion Devices
        • Blood Warmers
        • Venous Access Devices
        • Filters
        • Others
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Apheresis Systems
        • Infusion Devices
        • Blood Warmers
        • Venous Access Devices
        • Filters
        • Others
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Apheresis Systems
        • Infusion Devices
        • Blood Warmers
        • Venous Access Devices
        • Filters
        • Others
      • By End User:
        • Hospital
        • Ambulatory Surgical Centers
        • Others
  • Company Profiles
    • Fresenius Kabi AG
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Grifols, S.A.
    • Tenko International Group Corp
    • Terumo Corporation
    • Kawasumi Laboratories, Inc.
    • Haemonetics Corporation
    • Bioelectronica MILANO
    • RAYS S.P.A.
    • Macopharma SA
    • Braun Melsungen AG
    • Baxter International Inc.
    • Neomedic Limited
    • 3M Company

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The CAGR of the blood transfusion devices market is expected to be 5.7% during the forecast period (2020-2027).
The value of blood transfusion devices market is estimated to be US$ 4,189.6 million in 2020.
The prominent players in the global blood transfusion devices market include Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company
The blood transfusion devices market is expected to be valued at US$ 6,209.4 Mn in 2027.
North America is the major region in the blood transfusion devices market.
The increasing prevalence of blood-related disorders and chronic kidney disorders and increasing Launches of Blood Transfusion Devices are expected to drive growth of the global blood transfusion devices market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo